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The tremendous success of cardiology has led to symptomatic cardiovascular disease 
developing later in life and the prolongation of survival when clinically overt disease does 
develop.1-4 As a result, even though age-adjusted incidence of cardiovascular problems may 
be falling, the prevalence of many is increasing because of lengthening survival.1-4 Even 
cardiac conditions that were once relatively acute in onset and often rapidly fatal have now 
become chronic diseases.5,6 Our clinics and wards in the more developed regions of the world 
are full of increasingly elderly patients with multiple chronic cardiovascular and other 
problems, often treated with an even larger number of pharmacological therapies.7 In parallel 
with these staggering demographic changes, cardiology and medicine in general has changed. 
Cardiology has become more and more technology driven and the delivery of medical care 
has become increasingly disjointed. Doctors feel they have less time to offer their patients 
and patients are often bewildered by the variety of specialisms involved in their care and 
exhausted by the many different clinics they (and often their spouses as well) are asked to 
attend. Treatment adherence is a challenge for many. As a result, ever more vulnerable and 
complex patients may not receive the comprehensive, individually optimised, evidence-
based, care that can make a difference for them, health care systems and societies. The 
apparently ever growing numbers of emergency department visits, hospital admissions and 
re-admissions are the result of the interaction between these and other factors.  
 
What can we do about it? Stewart and colleagues propose one possible solution in this issue 
of Circulation.8 In a remarkable report, they summarize the results of three trials and many 
years of work testing the value of nurse-led, multi-disciplinary, home-based intervention in 
cardiovascular diseases. They found that this intervention led to large relative and absolute 
risk-reductions in death and hospital admission in patients with heart failure, atrial fibrillation 
and other cardiovascular diseases (mainly coronary heart disease). Critically, the primary 
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clinical outcome examined by the authors, days alive and out of hospital (or days of hospital-
free survival) is a particularly objective and robust measure of total mortality and morbidity, 
resembling all-cause death or all-cause hospitalization in a traditional time-to-first-event 
analysis but also taking account of recurrent non-fatal events.  The benefits of this type of 
patient-centred intervention involving human beings rather than machines have already been 
particularly well documented in heart failure and stand in striking contrast to a number of 
different attempts to find a technological alternative that can deliver the same benefits in 
heart failure.9-12 The present report extends the evidence for home-based intervention to other 
cardiovascular problems, although, in truth, this is hardly surprising given that few patients 
have heart failure, atrial fibrillation or coronary heart disease in isolation and many have all 
together and usually more problems as well. As always, innovative clinical research like this 
raises more questions. The numbers of patients and events (especially deaths) was relatively 
small. The trials were conducted by the same highly expert team in one country with a 
particular type of health care system. For cardiologists used to reading about the effects of a 
drug or a device, the nature of the intervention seems complex and cannot be described in a 
few words. Because the intervention is multifaceted, which, if any component, is more or less 
important has been the subject of question, if not controversy, especially the “home-based” 
i.e. home visiting component.13-15 In some cultures, the nurse who is an expert in disease 
management and also a prescriber is still not widely accepted. In others, home visits might 
not be possible. However, in others such as Germany, disease management programs for 
coronary heart disease and even non-cardiovascular diseases such as diabetes are more or less 
universal.16 
 
Where do we go from here? The value of disease management programs for heart failure is 
widely accepted and endorsed by guidelines.17,18 Indeed, they may offer the best unified 
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framework for putting guidelines into practice (which may account for much of their success) 
and joining up disjointed health care systems. However, the content of these programs varies 
and implementation is restricted to certain regions of the world. Guidelines generally require 
multiple studies to give the strongest endorsement to treatments. Therefore, it would be good 
to see the authors’ findings in atrial fibrillation and other types of cardiovascular disease 
replicated elsewhere and blueprints for such interventions exist, although, in truth, each of 
these programs would inevitably incorporate management strategies for the other problem 
(and heart failure as well) because many patients have two or all three problems and the 
interventions are, by definition, holistic.19 Financial support for such non-drug, non-device 
interventions of no interest to industry is notoriously hard to come by and there really is no 
mechanism to fund what is really needed i.e. large, prospective, multi-center, multi-national, 
randomized controlled trials. Maybe technology (which on its own has largely failed) can be 
integrated into such programs and funding found in that way. Eventually, however, 
governments, health care providers and payers will have to look for a solution to the 
problems described at the start of this article and Stewart et al have provided them with a 
glimpse of what the future might looks like if they are prepared to invest in proving it. 
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